Prochazka et al reported a simple score for evaluating elderly patients with diffuse large B-cell lymphoma (DLBCL). The authors are from Palacky University, Charles University, Masaryk University, and University Hospital Hradec Kralove in the Czech Republic.
Patient selection: age >= 60 years with diffuse large B-cell lymphoma treated with R-CHOP
This is similar to the ABE3 score, except that it has 4 categories instead of 3.
Parameters:
(1) age (A)
(2) bulky disease (B), >= 7.5 cm in diameter
(3) ECOG performance status (E)
Parameter |
Finding |
Points |
age |
60 to 69 years |
0 |
|
>= 70 years of age |
1 |
bulky disease |
no |
0 |
|
yes |
1 |
ECOG |
0 |
0 |
|
1 to 4 |
1 |
total score =
= SUM(points for all 3 parameters)
Interpretation:
• minimum score: 0
• maximum score: 3
• The pattern of the 3 parameters can also be used to separate patients into prognostic groups.
• The grade reflects the score (Grade I has a score of 1, Grade II 2, Grade III 3).
Age |
Bulky |
ECOG |
Risk (Grade) |
0 |
0 |
0 |
low (0) |
1 |
0 |
0 |
low-intermediate (I) |
0 |
1 |
0 |
low-intermediate (I) |
0 |
0 |
1 |
low-intermediate (I) |
1 |
0 |
1 |
high-intermediate (II) |
0 |
1 |
1 |
high-intermediate (II) |
1 |
1 |
0 |
high-intermediate (II) |
1 |
1 |
1 |
high (III) |
Risk Group |
3-Year Overall Survival |
low |
94% |
low-intermediate |
77% |
high-intermediate |
63% |
high |
35% |
Specialty: Hematology Oncology